The object of treating patients with glaucoma is to pre serve vision. The pathological mechanisms resulting in glaucoma are varied and alter the approach to manage ment. In general, treatment is aimed at lowering intra ocular pressure to a level believed to be safe for that particular eye at that stage of disease.
Therapy is aimed at reducing aqueous production or at improving outflow either through the existing outflow pathway or by alternatively created drainage channels. In no other area of ophthalmology have there been more varied attempts at finding a cure.
In discussing the use of lasers in treating glaucoma it would be wrong to assume that they cannot be invasive to varying degrees, but they have achieved some reduction in the risk of ocular damage in certain situations. For example, laser iridectomy with the neodymium: Y AG laser has achieved the creation of a functional opening in iris tissue in angle closure disease without incising the sur face tissue of the eye. In most cases this facilitates the management of this disease and certainly aids prevention when used prophylactically in the fellow eye. Lasers per haps represent a concept of a more precise and less trau matic method of performing certain surgical tasks without necessarily invading the integrity of the globe. This is cer tainly their image in the mind of the public, though to some extent it also exists in our minds as surgeons in con templating their use.
We could, however, hardly consider neodymium: Y AG cyclophotocoagulation and iridectomy in the same breath, even though both use infrared light at 1064 nm and only the press of a switch is required to convert Q-switched pulses to longer free-running thermal emission. Cyclo Y AG follows in the footsteps of cyclocryotherapy as another weapon against refractory disease, and although the globe remains visibly unperforated the energy levels delivered to the eye, deep to the surface, are sufficient to produce extensive tissue damage to the target zone as well as a variable degree of undesirable inflammatory response. Its place in therapy can be defended by virtue of We know that argon laser trabeculoplasty does not replace filtering procedures and that its effect is more akin to adding an additional medication to the eye, with pres sure lowering of 6 or 7 mmHg being the usual maximum.
In those cases where this degree of pressure lowering is sufficient when added to other therapy, visual loss may well be halted for a variable period of time. I think, though, that we are all concerned that the use of the procedure might in some cases delay conventional surgery once visual loss is occurring. However, we have perhaps been too ready to denounce argon laser trabeculoplasty because of its modest contribution and in the light of its possible deleterious effect on subs�quent filtering surgery; there are patients who do remarkably well for long periods after treatment and it should not lightly be dismissed. The goal of all these laser approaches is the same, and they must be put to the same stringent tests as have been applied by virtue of the weight of clinical experience with trabeculectomy. Firstly, they must be shown in animal studies to be possible and apparently safe. Secondly, care ful trials are required to extend awareness of safety and exact techniques. Thirdly, and this is the most difficult cri terion to satisfy, they must withstand the test of time in comparison with existing surgical filtration methods. We must not presume that a new technique, whether it be with a laser or not, is necessarily an advantage, but it must be open to consideration as to whether producing filtration by an alternative method to trabeculectomy can make a genu ine contribution to preventing patients suffering loss of vision as a result of glaucoma. The laser techniques described above, including laser trabeculoplasty, need not necessarily be dismissed as unsuccessful if they need additional medication, provided the treatment goal is achieved of successfully lowering the intraocular pressure to a level which maintains, or is believed to maintain, vision and stable visual fields. We are only at the begin ning of laser surgery for glaucoma and the prospects remain exciting.
